M. Gao

发表

CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Li Yang, Li Yang, He Huang, 2021, Clinical Cancer Research.

Vibsanin B Preferentially Targets HSP90β, Inhibits Interstitial Leukocyte Migration, and Ameliorates Experimental Autoimmune Encephalomyelitis

Saijuan Chen, Zhu Chen, Yin-yin Xie, 2015, The Journal of Immunology.

HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.

Yong Zhou, M. Gao, Hai-ping Wang, 2006, Vaccine.

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

He Huang, G. Wei, Q. Mu, 2022, Cell Research.

1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3

A. Lok, K. Reddy, P. Thuluvath, 2012 .

Relatively Low Level of Antigen-specific Monocytes Detected in Blood from Untreated Tuberculosis Patients Using CD4+ T-cell Receptor Tetramers

D. Xie, Yimin Fang, Lifang Jiang, 2012, PLoS pathogens.

Interleukin-16 does not suppress HIV-1 replication in naturally infected peripheral blood mononuclear cells.

S. Owatari, H. Tsuchie, K. Yoshizaki, 1997, AIDS.

Difference in susceptibility to CC chemokines among HIV 1 isolates

H. Tsuchie, T. Kurimura, K. Taniguchi, 1998, International journal of STD & AIDS.

Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.

S. Ueda, S. Owatari, T. Katsumoto, 1996, Acta virologica.